What Salutas Pharma GmbH does

Salutas Pharma GmbH is a Germany-based pharmaceutical manufacturer operating two production facilities in Barleben and Osterweddingen, with a total headcount of 206 employees. The company is referenced within the Sandoz Deutschland corporate footprint, indicating it functions as a manufacturing subsidiary within Sandoz, one of the world's largest generics pharmaceutical companies. The two sites are classified as manufacturing/production facilities, consistent with Salutas Pharma's role as a production node rather than a standalone commercial entity with its own go-to-market. The company's corporate domicile is Germany, and its entire disclosed operational footprint is domestic.

No specific products, formulations, or technology stack are disclosed in the available source data. As a Sandoz-affiliated generics manufacturer, Salutas Pharma's implied product surface is solid oral dosage forms and other generic pharmaceutical formats typical of large-scale European generics manufacturing, but this is inferred from the parent company context rather than explicitly stated. There is no disclosed AI capability, no proprietary technology platform, no patents, and no certifications documented in the source. The company does not disclose an app, API, or software product.

The business model is implicit but not formalized in the source data. Salutas Pharma is a private subsidiary (per the source's classification, though ownership name is not declared) engaged in pharmaceutical manufacturing. Pricing models, revenue mechanics, and customer segments are not disclosed. Given the Sandoz parent relationship, the most plausible model is internal capacity contribution to Sandoz's European generics supply, with commercial revenue captured at the parent-group level rather than at the entity level. The company has no disclosed partnerships, no M&A history, no funding rounds, and no management team data in the provided input.

Name

Salutas Pharma GmbH

Website

https://salutas.de

Company type

Private

Operating status

Operating

Headcount range

101–250 employees

Short description

Salutas Pharma GmbH is a German pharmaceutical manufacturer operating two production sites in Barleben and Osterweddingen within the Sandoz group, employing 206 staff in generics manufacturing.

Ownership category

akta.pro rank

Product category

Generic Pharmaceuticals

NAICS

Pharmaceutical Preparation Manufacturing (325412), Pharmaceutical and Medicine Manufacturing (32541)

SIC

Pharmaceutical Preparations (2834)

akta.pro primary industry

Generic Finished Dosage Form (FDF) Manufacturing (HLAIABAH)

akta.pro secondary industries

Small-Molecule Generics (Branded/Unbranded) (HLAIABAA), Generic APIs & Intermediates (Active Ingredients) (HLAIABAG), Oral Solid Dose (OSD) Generics (HLAIABAD)

Keywords

• Generic pharmaceuticals
• Pharmaceutical manufacturing
• Oral solid dosage
• Active pharmaceutical ingredients
• Generic medicine production

Headquarters

HQ city

Barleben

HQ country

Germany

HQ region

Europe

Offices2 records

Markets served

GTM type

B2B

Offering type

Hardware or Manufacturing

Cost components

Personnel, Operations, Supply Chain, Technology or R&D

Core offering

Salutas Pharma GmbH operates as a German pharmaceutical manufacturer, with production sites in Barleben and Osterweddingen producing generic medicines. The company manufactures and supplies generic pharmaceutical products as part of the Sandoz manufacturing network, focusing on cost-efficient oral solid dosage generics for European and global markets.

Product overview

No product information available for Salutas Pharma GmbH in the provided source data. The source only references a Sandoz Deutschland page regarding manufacturing locations in Barleben und Osterweddingen, Germany.

Differentiator

Problem solved

Functional benefit

Products and services

• Generic pharmaceutical products (manufactured at Barleben and Osterweddingen sites) Generic medicines (including oral solid dosage forms) manufactured at Salutas Pharma's Barleben and Osterweddingen German production sites and supplied through the Sandoz generics network to wholesalers, pharmacy chains, and health systems globally.

Ideal customer profiles1 record

Technology focussed No

API detail

Has API

No

API docs

API detail

Core technology

AI maturity

App detail

Emerging players

• Alvotech: Alvotech is a biosimilars-focused manufacturer expanding its European manufacturing presence. While focused on biosimilars rather than small-molecule generics, it is emerging as a potential competitor for Sandoz-related manufacturing capacity and represents adjacent category pressure on Salutas.

Broad incumbents

• Apotex Inc. Apotex is a large global generic pharmaceutical manufacturer with European market presence. Comparable to Salutas as a generics broad incumbent active in small-molecule finished dosage forms, though primarily Canadian-headquartered.
• Viatris (Mylan): Viatris is a global generics and specialty pharmaceutical powerhouse with a broad European generics portfolio. Comparable to Salutas as a broad incumbent in the same product category, though at significantly greater scale and geographic diversification.
• Teva Pharmaceutical Industries: Teva is the world's largest generic pharmaceutical manufacturer with significant German operations through ratiopharm. While substantially larger and more diversified, it competes directly with Salutas in the broader European generics market.
• Hikma Pharmaceuticals: Hikma is a multinational generic pharmaceutical manufacturer with a European footprint. It competes with Salutas in European generic markets and shares the same business model of producing small-molecule generic finished dosage forms.

Direct peers

• Ratiopharm GmbH: Ratiopharm is a leading German generics brand (now part of Teva) with established manufacturing and a similar value proposition in the small-molecule generics market. Highly comparable to Salutas in product category and German market positioning.
• Hexal AG: Hexal is Sandoz's German sister subsidiary and one of the largest generics manufacturers in Germany. Directly comparable as a German-based generics operation within the same Sandoz group, operating in the same product categories and regulatory environment as Salutas.
• Stada Arzneimittel AG: Stada is a major German-headquartered generic pharmaceutical manufacturer with significant production in Germany. Directly comparable to Salutas in geography, therapeutic focus on generics, and European manufacturing footprint.
• Aurobindo Pharma Deutschland: Aurobindo's German operations supply generic finished dosage forms across European markets, giving it a directly comparable product portfolio and customer base to Salutas within the European generic pharmaceutical supply chain.

Regional players

• Merckle GmbH (Heumann / Haemato Pharma): Merckle is a German-based pharmaceutical group with manufacturing and generics activities. It is comparable to Salutas as a regional German pharmaceutical manufacturer with similar regulatory and market dynamics.

Market position

Strengths3 records

Weaknesses3 records

Competitive moat3 records

Key risks5 records

Key highlights5 records

Customer concentration

• LinkedInlinkedin.com/company/salutas-pharma-gmbh

Revenue estimate

Valuation estimate

Number of profiles

Funding overview

Funding rounds

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about Salutas Pharma GmbH